Huang Jane
Insider CIK 1683913 · TARA Director · BGNE CMO, Hematology · PRLD President, CMO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics, Inc. | A Award deriv | 2026-06-15 | 2026-06-16 | 31,000 | — | $0 | 31,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2025-10-04 | 2025-10-07 | 9,375 | — | $0 | 18,750 | SEC↗ |
| PRLD Prelude Therapeutics Inc | F Tax w/h | 2025-10-04 | 2025-10-07 | 3,355 | $1.47 | $4.9K | 86,917 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2025-10-04 | 2025-10-07 | 9,375 | — | $0 | 90,272 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2025-07-04 | 2025-07-08 | 9,375 | — | $0 | 28,125 | SEC↗ |
| PRLD Prelude Therapeutics Inc | F Tax w/h | 2025-07-04 | 2025-07-08 | 3,355 | $0.79 | $2.7K | 80,897 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2025-07-04 | 2025-07-08 | 9,375 | — | $0 | 84,252 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2025-04-04 | 2025-04-07 | 9,375 | — | $0 | 37,500 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2025-04-04 | 2025-04-07 | 9,375 | — | $0 | 78,232 | SEC↗ |
| PRLD Prelude Therapeutics Inc | F Tax w/h | 2025-04-04 | 2025-04-07 | 3,355 | $0.68 | $2.3K | 74,877 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2025-02-04 | 2025-02-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2025-01-04 | 2025-01-07 | 9,375 | — | $0 | 46,875 | SEC↗ |
| PRLD Prelude Therapeutics Inc | F Tax w/h | 2025-01-04 | 2025-01-07 | 3,859 | $1.39 | $5.4K | 68,857 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2025-01-04 | 2025-01-07 | 9,375 | — | $0 | 72,716 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2024-10-04 | 2024-10-07 | 9,375 | — | $0 | 56,250 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2024-10-04 | 2024-10-07 | 9,375 | — | $0 | 66,690 | SEC↗ |
| PRLD Prelude Therapeutics Inc | F Tax w/h | 2024-10-04 | 2024-10-07 | 3,349 | $2.00 | $6.7K | 63,341 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2024-07-04 | 2024-07-08 | 9,375 | — | $0 | 65,625 | SEC↗ |
| PRLD Prelude Therapeutics Inc | F Tax w/h | 2024-07-04 | 2024-07-08 | 3,347 | $3.60 | $12.0K | 57,315 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2024-07-04 | 2024-07-08 | 9,375 | — | $0 | 60,662 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2024-06-07 | 2024-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2024-04-04 | 2024-04-08 | 9,375 | — | $0 | 75,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | F Tax w/h | 2024-04-04 | 2024-04-08 | 3,347 | $4.74 | $15.9K | 51,287 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2024-04-04 | 2024-04-08 | 9,375 | — | $0 | 54,634 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2024-03-01 | 2024-03-04 | 175,000 | — | $0 | 175,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2024-01-04 | 2024-01-08 | 9,375 | — | $0 | 84,375 | SEC↗ |
| PRLD Prelude Therapeutics Inc | F Tax w/h | 2024-01-04 | 2024-01-08 | 3,844 | $3.77 | $14.5K | 45,259 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2024-01-04 | 2024-01-08 | 9,375 | — | $0 | 49,103 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2023-10-04 | 2023-10-06 | 9,375 | — | $0 | 93,750 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2023-10-04 | 2023-10-06 | 9,375 | — | $0 | 39,728 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2023-07-04 | 2023-07-06 | 9,375 | — | $0 | 103,125 | SEC↗ |
| PRLD Prelude Therapeutics Inc | F Tax w/h | 2023-07-04 | 2023-07-06 | 3,242 | $4.65 | $15.1K | 30,353 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2023-07-04 | 2023-07-06 | 9,375 | — | $0 | 33,595 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2023-04-06 | 2023-04-06 | 13,280 | $6.12 | $81.3K | 24,220 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2023-04-04 | 2023-04-06 | 37,500 | — | $0 | 112,500 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2023-04-04 | 2023-04-06 | 37,500 | — | $0 | 37,500 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2023-02-07 | 2023-02-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2022-05-02 | 2022-05-04 | 460,000 | — | $0 | 460,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2022-05-02 | 2022-05-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-12-14 | 2021-12-16 | 19,500 | — | $0 | 211,276 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-12-14 | 2021-12-16 | 500 | $278.21 | $139.1K | 400 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-12-14 | 2021-12-16 | 300 | $276.95 | $83.1K | 900 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-12-14 | 2021-12-16 | 100 | $284.52 | $28.5K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-12-14 | 2021-12-16 | 1,500 | $119.96 | $179.9K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-12-14 | 2021-12-16 | 100 | $278.79 | $27.9K | 300 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-12-14 | 2021-12-16 | 200 | $281.64 | $56.3K | 100 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-12-14 | 2021-12-16 | 300 | $274.54 | $82.4K | 1,200 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-12-01 | 2021-12-02 | 530 | $357.32 | $189.4K | 519 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-12-01 | 2021-12-02 | 519 | $362.45 | $188.1K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-11-30 | 2021-12-02 | 1,049 | — | $0 | 1,049 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-11-30 | 2021-12-02 | 14,820 | — | $0 | 160,055 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-11-17 | 2021-11-19 | 19,500 | — | $0 | 230,776 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-11-17 | 2021-11-19 | 100 | $384.16 | $38.4K | 400 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-11-17 | 2021-11-19 | 100 | $385.28 | $38.5K | 300 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-11-17 | 2021-11-19 | 200 | $381.41 | $76.3K | 600 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-11-17 | 2021-11-19 | 100 | $377.92 | $37.8K | 900 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-11-17 | 2021-11-19 | 100 | $382.42 | $38.2K | 500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-11-17 | 2021-11-19 | 300 | $377.14 | $113.1K | 1,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-11-17 | 2021-11-19 | 100 | $379.88 | $38.0K | 800 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-11-17 | 2021-11-19 | 300 | $387.94 | $116.4K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-11-17 | 2021-11-19 | 200 | $376.16 | $75.2K | 1,300 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-11-17 | 2021-11-19 | 1,500 | $119.96 | $179.9K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-10-19 | 2021-10-21 | 19,500 | — | $0 | 250,276 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-10-19 | 2021-10-21 | 100 | $370.14 | $37.0K | 1,200 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-10-19 | 2021-10-21 | 100 | $371.65 | $37.2K | 1,100 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-10-19 | 2021-10-21 | 400 | $373.75 | $149.5K | 700 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-10-19 | 2021-10-21 | 400 | $375.08 | $150.0K | 300 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-10-19 | 2021-10-21 | 1,500 | $119.96 | $179.9K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-10-19 | 2021-10-21 | 200 | $376.36 | $75.3K | 100 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-10-19 | 2021-10-21 | 100 | $377.71 | $37.8K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-10-19 | 2021-10-21 | 200 | $362.05 | $72.4K | 1,300 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-09-20 | 2021-09-22 | 78,000 | — | $0 | 269,776 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 100 | $390.91 | $39.1K | 5,900 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 100 | $408.69 | $40.9K | 100 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 150 | $407.98 | $61.2K | 200 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 200 | $406.86 | $81.4K | 350 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 583 | $401.86 | $234.3K | 550 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 400 | $400.58 | $160.2K | 1,133 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 400 | $399.00 | $159.6K | 1,533 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 790 | $398.37 | $314.7K | 1,933 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 700 | $397.15 | $278.0K | 2,723 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 700 | $396.00 | $277.2K | 3,423 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 913 | $395.13 | $360.8K | 4,123 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 328 | $393.34 | $129.0K | 5,036 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 536 | $392.40 | $210.3K | 5,364 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-20 | 2021-09-22 | 100 | $411.17 | $41.1K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-09-20 | 2021-09-22 | 6,000 | $119.96 | $719.8K | 6,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-13 | 2021-09-15 | 900 | $361.05 | $324.9K | 1,582 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-13 | 2021-09-15 | 4,219 | $355.37 | $1.50M | 8,682 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-13 | 2021-09-15 | 1,400 | $356.46 | $499.0K | 7,282 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-13 | 2021-09-15 | 1,300 | $357.54 | $464.8K | 5,982 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-13 | 2021-09-15 | 1,700 | $359.15 | $610.6K | 4,282 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-13 | 2021-09-15 | 1,800 | $359.88 | $647.8K | 2,482 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-13 | 2021-09-15 | 1,581 | $362.80 | $573.6K | 1 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-13 | 2021-09-15 | 1 | $363.45 | $363 | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-02 | 2021-09-02 | 545 | $327.18 | $178.3K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-09-01 | 2021-09-02 | 542 | $310.53 | $168.3K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-09-01 | 2021-09-02 | 545 | — | $0 | 545 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-09-01 | 2021-09-02 | 7,124 | — | $0 | 312,948 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-08-31 | 2021-09-02 | 7,163 | — | $0 | 305,824 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-08-31 | 2021-09-02 | 542 | — | $0 | 542 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-07-15 | 2021-07-19 | 114,803 | — | $0 | 347,776 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-07-15 | 2021-07-19 | 68,315 | — | $0 | 204,971 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-07-15 | 2021-07-19 | 89,882 | — | $0 | 122,798 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-07-15 | 2021-07-19 | 98 | $335.76 | $32.9K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-07-15 | 2021-07-19 | 1,000 | $334.85 | $334.9K | 98 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-07-15 | 2021-07-19 | 2,823 | $333.64 | $941.9K | 1,098 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-07-15 | 2021-07-19 | 8,177 | $332.71 | $2.72M | 3,921 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-07-15 | 2021-07-19 | 6,523 | $331.79 | $2.16M | 12,098 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-07-15 | 2021-07-19 | 6,914 | $160.40 | $1.11M | 6,914 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-07-15 | 2021-07-19 | 2,379 | $330.53 | $786.3K | 18,621 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-07-15 | 2021-07-19 | 5,255 | $174.43 | $916.6K | 21,000 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-07-15 | 2021-07-19 | 8,831 | $119.96 | $1.06M | 15,745 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-06-29 | 2021-06-30 | 19,500 | — | $0 | 207,575 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-29 | 2021-06-30 | 300 | $355.26 | $106.6K | 200 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-29 | 2021-06-30 | 200 | $352.95 | $70.6K | 500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-29 | 2021-06-30 | 200 | $356.98 | $71.4K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-29 | 2021-06-30 | 400 | $351.06 | $140.4K | 700 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-29 | 2021-06-30 | 100 | $349.22 | $34.9K | 1,100 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-29 | 2021-06-30 | 300 | $347.63 | $104.3K | 1,200 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-06-29 | 2021-06-30 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-28 | 2021-06-30 | 425 | $365.00 | $155.1K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-18 | 2021-06-21 | 469 | $325.66 | $152.7K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2021-06-16 | 2021-06-21 | 157,196 | — | $0 | 157,196 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-06-16 | 2021-06-21 | 25,350 | — | $0 | 304,186 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2021-06-09 | 2021-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2021-06-09 | 2021-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-07 | 2021-06-09 | 603 | $351.55 | $212.0K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-06-01 | 2021-06-02 | 540 | $362.64 | $195.8K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-05-31 | 2021-06-02 | 7,189 | — | $0 | 292,772 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-05-31 | 2021-06-02 | 540 | — | $0 | 540 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-05-28 | 2021-06-02 | 19,500 | — | $0 | 227,075 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-05-28 | 2021-06-02 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-05-28 | 2021-06-02 | 100 | $352.85 | $35.3K | 1,400 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-05-28 | 2021-06-02 | 500 | $354.97 | $177.5K | 900 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-05-28 | 2021-06-02 | 300 | $356.21 | $106.9K | 600 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-05-28 | 2021-06-02 | 353 | $357.50 | $126.2K | 247 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-05-28 | 2021-06-02 | 147 | $358.36 | $52.7K | 100 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-05-28 | 2021-06-02 | 100 | $359.42 | $35.9K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-04-29 | 2021-05-03 | 19,500 | — | $0 | 246,575 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-04-29 | 2021-05-03 | 200 | $352.67 | $70.5K | 1,200 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-04-29 | 2021-05-03 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-04-29 | 2021-05-03 | 100 | $350.25 | $35.0K | 1,400 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-04-29 | 2021-05-03 | 300 | $353.94 | $106.2K | 900 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-04-29 | 2021-05-03 | 200 | $358.62 | $71.7K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-04-29 | 2021-05-03 | 300 | $356.25 | $106.9K | 200 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-04-29 | 2021-05-03 | 400 | $355.12 | $142.0K | 500 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-03-29 | 2021-03-31 | 19,500 | — | $0 | 266,075 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-03-29 | 2021-03-31 | 395 | $323.31 | $127.7K | 805 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-03-29 | 2021-03-31 | 200 | $325.56 | $65.1K | 227 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-03-29 | 2021-03-31 | 378 | $324.14 | $122.5K | 427 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-03-29 | 2021-03-31 | 227 | $326.29 | $74.1K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-03-29 | 2021-03-31 | 300 | $321.94 | $96.6K | 1,200 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-03-29 | 2021-03-31 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-02-26 | 2021-03-02 | 19,500 | — | $0 | 285,575 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-02-26 | 2021-03-02 | 100 | $315.62 | $31.6K | 1,400 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-02-26 | 2021-03-02 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-02-26 | 2021-03-02 | 100 | $317.52 | $31.8K | 1,300 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-02-26 | 2021-03-02 | 300 | $319.67 | $95.9K | 1,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-02-26 | 2021-03-02 | 400 | $321.21 | $128.5K | 600 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-02-26 | 2021-03-02 | 600 | $322.33 | $193.4K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2021-01-29 | 2021-02-02 | 19,500 | — | $0 | 305,075 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-29 | 2021-02-02 | 300 | $322.51 | $96.8K | 500 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2021-01-29 | 2021-02-02 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-29 | 2021-02-02 | 300 | $318.48 | $95.5K | 1,200 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-29 | 2021-02-02 | 393 | $319.61 | $125.6K | 807 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-29 | 2021-02-02 | 7 | $320.81 | $2.2K | 800 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-29 | 2021-02-02 | 100 | $323.85 | $32.4K | 400 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-29 | 2021-02-02 | 200 | $331.46 | $66.3K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-29 | 2021-02-02 | 100 | $330.05 | $33.0K | 200 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2021-01-29 | 2021-02-02 | 100 | $326.58 | $32.7K | 300 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-12-29 | 2020-12-30 | 19,500 | — | $0 | 324,575 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-29 | 2020-12-30 | 300 | $252.86 | $75.9K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-29 | 2020-12-30 | 300 | $251.58 | $75.5K | 300 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-29 | 2020-12-30 | 200 | $249.88 | $50.0K | 600 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-29 | 2020-12-30 | 200 | $247.98 | $49.6K | 800 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-29 | 2020-12-30 | 300 | $246.02 | $73.8K | 1,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-12-29 | 2020-12-30 | 200 | $244.90 | $49.0K | 1,300 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-12-29 | 2020-12-30 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-11-30 | 2020-12-02 | 19,500 | — | $0 | 344,075 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 100 | $277.22 | $27.7K | 196 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-11-30 | 2020-12-02 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 104 | $256.00 | $26.6K | 1,396 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 100 | $260.06 | $26.0K | 1,296 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 96 | $285.05 | $27.4K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 100 | $278.92 | $27.9K | 96 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 200 | $262.06 | $52.4K | 1,096 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 100 | $275.45 | $27.5K | 296 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 100 | $269.05 | $26.9K | 396 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 300 | $266.75 | $80.0K | 496 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 200 | $264.50 | $52.9K | 796 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 100 | $263.28 | $26.3K | 996 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-10-29 | 2020-11-02 | 19,500 | — | $0 | 363,575 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-29 | 2020-11-02 | 100 | $301.51 | $30.2K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-10-29 | 2020-11-02 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-29 | 2020-11-02 | 139 | $300.70 | $41.8K | 100 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-10-29 | 2020-11-02 | 1,261 | $299.88 | $378.1K | 239 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-09-29 | 2020-10-01 | 19,500 | — | $0 | 383,075 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-29 | 2020-10-01 | 730 | $280.65 | $204.9K | 570 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-29 | 2020-10-01 | 102 | $283.83 | $29.0K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-09-29 | 2020-10-01 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-29 | 2020-10-01 | 468 | $281.75 | $131.9K | 102 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-29 | 2020-10-01 | 200 | $274.42 | $54.9K | 1,300 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-03 | 2020-09-08 | 217 | $235.21 | $51.0K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-03 | 2020-09-08 | 1,000 | $232.25 | $232.3K | 2,128 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-03 | 2020-09-08 | 1,411 | $232.94 | $328.7K | 717 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-09-03 | 2020-09-08 | 500 | $234.17 | $117.1K | 217 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-08-28 | 2020-09-01 | 39,000 | — | $0 | 402,575 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-08-28 | 2020-09-01 | 200 | $240.86 | $48.2K | 2,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-08-28 | 2020-09-01 | 700 | $243.49 | $170.4K | 300 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-08-28 | 2020-09-01 | 1,000 | $242.41 | $242.4K | 1,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-08-28 | 2020-09-01 | 300 | $244.93 | $73.5K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-08-28 | 2020-09-01 | 800 | $240.15 | $192.1K | 2,200 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-08-28 | 2020-09-01 | 3,000 | $29.49 | $88.5K | 3,000 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-07-29 | 2020-07-31 | 19,500 | — | $0 | 441,575 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-07-29 | 2020-07-31 | 19,500 | — | $0 | 212,680 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-07-29 | 2020-07-31 | 1,500 | $160.40 | $240.6K | 3,000 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-07-29 | 2020-07-31 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-07-29 | 2020-07-31 | 399 | $213.56 | $85.2K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-07-29 | 2020-07-31 | 1,301 | $208.35 | $271.1K | 1,699 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-07-29 | 2020-07-31 | 700 | $208.91 | $146.2K | 999 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-07-29 | 2020-07-31 | 400 | $212.53 | $85.0K | 399 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-07-29 | 2020-07-31 | 200 | $211.31 | $42.3K | 799 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-07-07 | 2020-07-09 | 50,973 | — | $0 | 232,180 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-07-07 | 2020-07-09 | 3,921 | $200.00 | $784.2K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-07-07 | 2020-07-09 | 3,921 | $160.40 | $628.9K | 3,921 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-06-29 | 2020-06-30 | 19,500 | — | $0 | 461,075 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-29 | 2020-06-30 | 435 | $192.46 | $83.7K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-06-29 | 2020-06-30 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-29 | 2020-06-30 | 300 | $187.91 | $56.4K | 1,200 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-29 | 2020-06-30 | 402 | $188.95 | $76.0K | 798 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-29 | 2020-06-30 | 500 | $191.37 | $95.7K | 298 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-29 | 2020-06-30 | 198 | $192.72 | $38.2K | 100 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-29 | 2020-06-30 | 100 | $193.56 | $19.4K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-06-26 | 2020-06-30 | 27,027 | — | $0 | 283,153 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-26 | 2020-06-30 | 700 | $200.29 | $140.2K | 700 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-06-26 | 2020-06-30 | 2,079 | $160.40 | $333.5K | 2,079 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-26 | 2020-06-30 | 700 | $200.30 | $140.2K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-26 | 2020-06-30 | 679 | $200.27 | $136.0K | 1,400 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2020-06-17 | 2020-06-19 | 273,286 | — | $0 | 273,286 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2020-06-17 | 2020-06-19 | 48,438 | — | $0 | 331,902 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-06-08 | 2020-06-10 | 631 | $170.84 | $107.8K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-05-29 | 2020-06-02 | 19,500 | — | $0 | 480,575 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-05-29 | 2020-06-02 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-05-29 | 2020-06-02 | 500 | $162.63 | $81.3K | 1,000 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-05-29 | 2020-06-02 | 569 | $163.97 | $93.3K | 431 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-05-29 | 2020-06-02 | 431 | $165.12 | $71.2K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-04-29 | 2020-04-30 | 19,500 | — | $0 | 500,075 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-04-29 | 2020-04-30 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-04-29 | 2020-04-30 | 1,500 | $162.30 | $243.5K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-04-16 | 2020-04-17 | 19,500 | — | $0 | 519,575 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-04-16 | 2020-04-17 | 1,500 | $160.00 | $240.0K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-04-16 | 2020-04-17 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-02-18 | 2020-02-20 | 19,500 | — | $0 | 539,075 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-02-18 | 2020-02-20 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-02-18 | 2020-02-20 | 1,179 | $170.01 | $200.4K | 321 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-02-18 | 2020-02-20 | 321 | $171.14 | $54.9K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2020-01-21 | 2020-01-22 | 19,500 | — | $0 | 558,575 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2020-01-21 | 2020-01-22 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-01-21 | 2020-01-22 | 87 | $172.34 | $15.0K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-01-21 | 2020-01-22 | 600 | $171.27 | $102.8K | 87 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2020-01-21 | 2020-01-22 | 813 | $170.09 | $138.3K | 687 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2019-12-16 | 2019-12-18 | 19,500 | — | $0 | 578,075 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-12-16 | 2019-12-18 | 100 | $165.55 | $16.6K | 500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-12-16 | 2019-12-18 | 100 | $172.13 | $17.2K | 100 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-12-16 | 2019-12-18 | 200 | $170.73 | $34.1K | 200 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-12-16 | 2019-12-18 | 100 | $168.90 | $16.9K | 400 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-12-16 | 2019-12-18 | 100 | $173.59 | $17.4K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-12-16 | 2019-12-18 | 800 | $161.93 | $129.5K | 600 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-12-16 | 2019-12-18 | 100 | $160.07 | $16.0K | 1,400 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2019-12-16 | 2019-12-18 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2019-11-18 | 2019-11-20 | 19,500 | — | $0 | 597,575 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 100 | $198.93 | $19.9K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 500 | $193.63 | $96.8K | 800 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2019-11-18 | 2019-11-20 | 1,500 | $29.49 | $44.2K | 1,500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 200 | $192.24 | $38.4K | 1,300 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 95 | $195.82 | $18.6K | 100 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-18 | 2019-11-20 | 605 | $195.01 | $118.0K | 195 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2019-11-04 | 2019-11-06 | 427,700 | — | $0 | 617,075 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-04 | 2019-11-06 | 12,523 | $190.00 | $2.38M | 15,808 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2019-11-04 | 2019-11-06 | 32,900 | $29.49 | $970.2K | 32,900 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-04 | 2019-11-06 | 300 | $192.77 | $57.8K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-04 | 2019-11-06 | 4,569 | $189.08 | $863.9K | 28,331 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-04 | 2019-11-06 | 12,654 | $191.01 | $2.42M | 3,154 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-11-04 | 2019-11-06 | 2,854 | $191.96 | $547.9K | 300 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-09-04 | 2019-09-05 | 82 | $129.40 | $10.6K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-09-03 | 2019-09-05 | 230 | $144.94 | $33.3K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-09-03 | 2019-09-05 | 2,632 | $144.41 | $380.1K | 230 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2019-08-12 | 2019-08-13 | 32,500 | — | $0 | 850,465 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-08-12 | 2019-08-13 | 500 | $136.91 | $68.5K | 0 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-08-12 | 2019-08-13 | 800 | $135.86 | $108.7K | 500 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-08-12 | 2019-08-13 | 400 | $134.34 | $53.7K | 1,300 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-08-12 | 2019-08-13 | 800 | $132.47 | $106.0K | 1,700 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise | 2019-08-12 | 2019-08-13 | 2,500 | $45.31 | $113.3K | 2,500 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2019-07-29 | 2019-07-31 | 65,000 | — | $0 | 882,965 | SEC↗ |
| BGNE BeiGene, Ltd. | M Exercise deriv | 2019-07-29 | 2019-07-31 | 66,690 | — | $0 | 1,044,775 | SEC↗ |
| BGNE BeiGene, Ltd. | S Sale | 2019-07-29 | 2019-07-31 | 7,630 | $135.10 | $1.03M | 0 | SEC↗ |